Zynex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zynex and buy or sell other stocks, ETFs, and their options commission-free!

About ZYXIQ

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. 

CEO
Steven Lewis Dyson, PhD
CEOSteven Lewis Dyson, PhD
Employees
Employees
Headquarters
Englewood, Colorado
HeadquartersEnglewood, Colorado
Founded
1996
Founded1996
Employees
Employees

ZYXIQ Key Statistics

Market cap
1.67M
Market cap1.67M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
81.87K
Average volume81.87K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.145
52 Week high$0.145
52 Week low
$0.0203
52 Week low$0.0203

Stock Snapshot

With a market cap of 1.67M, Zynex(ZYXIQ) trades at $0.06. The stock has a price-to-earnings ratio of -0.02.

On 2026-07-26, Zynex(ZYXIQ) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Zynex(ZYXIQ) stock has reached 0, versus its average volume of 81.87K.

The stock's 52-week range extends from a low of $0.02 to a high of $0.15.

The stock's 52-week range extends from a low of $0.02 to a high of $0.15.

People also own

Based on the portfolios of people who own ZYXIQ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.